These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37359405)

  • 21. Implementation of precision medicine in healthcare-A European perspective.
    Stenzinger A; Moltzen EK; Winkler E; Molnar-Gabor F; Malek N; Costescu A; Jensen BN; Nowak F; Pinto C; Ottersen OP; Schirmacher P; Nordborg J; Seufferlein T; Fröhling S; Edsjö A; Garcia-Foncillas J; Normanno N; Lundgren B; Friedman M; Bolanos N; Tatton-Brown K; Hill S; Rosenquist R
    J Intern Med; 2023 Oct; 294(4):437-454. PubMed ID: 37455247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How can we deliver on the promise of precision medicine in oncology and beyond? A practical roadmap for action.
    Baird AM; Westphalen CB; Blum S; Nafria B; Knott T; Sargeant I; Harnik H; Brooke N; Wicki N; Wong-Rieger D
    Health Sci Rep; 2023 Jun; 6(6):e1349. PubMed ID: 37359405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stakeholders' expectations of precision medicine: A qualitative study to identify areas of (mis)alignment.
    Knott T; Creeden J; Horbach B; Rauch-Zumbrägel M; Vat L; Harnik H; Maravic Z
    Health Sci Rep; 2023 Aug; 6(8):e1428. PubMed ID: 37599652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.
    Truglio-Londrigan M; Slyer JT; Singleton JK; Worral P
    JBI Libr Syst Rev; 2012; 10(58):4633-4646. PubMed ID: 27820528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Roadmap toward Personalized Medicine: Challenges and Opportunities.
    Cinti C; Trivella MG; Joulie M; Ayoub H; Frenzel M;
    J Pers Med; 2024 May; 14(6):. PubMed ID: 38929767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar.
    Qoronfleh MW; Chouchane L; Mifsud B; Al Emadi M; Ismail S
    Life Sci Soc Policy; 2020 Nov; 16(1):12. PubMed ID: 33129349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients' and professionals' views related to ethical issues in precision medicine: a mixed research synthesis.
    Erdmann A; Rehmann-Sutter C; Bozzaro C
    BMC Med Ethics; 2021 Aug; 22(1):116. PubMed ID: 34465328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spinal muscular atrophy: From approved therapies to future therapeutic targets for personalized medicine.
    Chaytow H; Faller KME; Huang YT; Gillingwater TH
    Cell Rep Med; 2021 Jul; 2(7):100346. PubMed ID: 34337562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC.
    Grant MJ; Herbst RS; Goldberg SB
    Nat Rev Clin Oncol; 2021 Oct; 18(10):625-644. PubMed ID: 34168333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer.
    Rebuzzi SE; Zullo L; Rossi G; Grassi M; Murianni V; Tagliamento M; Prelaj A; Coco S; Longo L; Dal Bello MG; Alama A; Dellepiane C; Bennicelli E; Malapelle U; Genova C
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scaling Genetic Counseling in the Genomics Era.
    Amendola LM; Golden-Grant K; Scollon S
    Annu Rev Genomics Hum Genet; 2021 Aug; 22():339-355. PubMed ID: 33722076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Druggable genome and precision medicine in cancer: current challenges.
    Dupont CA; Riegel K; Pompaiah M; Juhl H; Rajalingam K
    FEBS J; 2021 Nov; 288(21):6142-6158. PubMed ID: 33626231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. My Data, My Choice? - German Patient Organizations' Attitudes towards Big Data-Driven Approaches in Personalized Medicine. An Empirical-Ethical Study.
    Rauter CM; Wöhlke S; Schicktanz S
    J Med Syst; 2021 Feb; 45(4):43. PubMed ID: 33616768
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.